Publikationen pro Jahr
Publikationen pro Jahr
Publikationen
- 14 Ergebnisse
Suchergebnisse
-
2022
1255 Impact of immune checkpoint inhibitors on bone turnover in cancer patients: prospective clinical study and preclinical correlates
Gassner, T., Vallet, S., Chittilappilly, C., Pirich, T., Lind, J., Aksoy, O., Sunder-Plassmann, V., Hackner, K., Zwickl-Traxler, E., Errhalt, P., Pecherstorfer, M. & Podar, K., 2022, in: Journal for ImmunoTherapy of Cancer. S. A1300-A1300Publikation: Beitrag in Fachzeitschrift (peer-reviewed) › Konferenzbeitrag in Fachzeitschrift
Open Access -
23P Enriching for response: Patient selection criteria for A2AR inhibition by EXS-21546 through ex vivo modelling in primary patient material
Vladimer, G., Alt, I., Sehlke, R., Lobley, A., Baumgärtler, C., Stulic, M., Hackner, K., Dzurillova, L., Petru, E., Hadjari, L., Lafleur, J., Singer, J., Krall, N., Šufliarsky, J., Hefler, L., Fuereder, T., Taubert, C., Boudesco, C. & Payne, A., 01 Dez. 2022, in: Immuno-Oncology and Technology. 16, S. 100128Publikation: Beitrag in Fachzeitschrift (peer-reviewed) › Konferenzbeitrag in Fachzeitschrift
Open Access -
Defining activity and patient selection of a novel CDK7 inhibitor, GTAEXS-617, through AI-supported primary cancer tissue profiling
Somlyay, M., Durinikova, E., Besnard, J., Barbeau, O., Le Coz, J., Senekowitsch, M., Ergüner, B., Hackner, K., Dzurillova, L., Petru, E., Lafleur, J., Singer, J., Füreder, T., Paveley, R., Joseph, J., Aswad, F., Winkler-Penz, T., Sehlke, R., Boudesco, C. & Vladimer, G., Okt. 2022, in: European Journal of Cancer. 174, S. S44-S45Publikation: Beitrag in Fachzeitschrift (peer-reviewed) › Konferenzbeitrag in Fachzeitschrift
Open Access -
P-283: TRIATLON - triple class exposed/refractory multipLe myeloma patients: a real world analysis (RWA) from the Austrian Myeloma Registry (AMR)
Willenbacher, E., Pichler, P., Strassl, I., Krauth, M., Agis, H., Sormann, S., Hartmann, B., Podar, K., Weger, R. & Willenbacher, W., 01 Aug. 2022, in: Clinical Lymphoma, Myeloma and Leukemia. 22, S. S193-S194Publikation: Beitrag in Fachzeitschrift (peer-reviewed) › Konferenzbeitrag in Fachzeitschrift
-
S179: RANDOMIZED COMPARISON BETWEEN KRD AND KTD INDUCTION, FOLLOWED BY K MAINTENANCE OR OBSERVATION IN TRANSPLANT NON-ELIGIBLE PATIENTS WITH NDMM (AGMT-MM02 TRIAL)
Ludwig, H., Melchardt, T., Sormann, S., Zojer, N., Andel, J., Hartmann, B., Tinchon, C., Gunsilius, E., Podar, K., Egle, A., Willenbacher, W., Wöll, E., Schreder, M., Ruckser, R., Bozic, B., Krauth, M. T., Petzer, A., Schmitt, C., Machherndl-Spandl, S., Agis, H., &5 mehr, 2022, in: HemaSphere. 6, S. 80-81Publikation: Beitrag in Fachzeitschrift (peer-reviewed) › Konferenzbeitrag in Fachzeitschrift
Open Access -
2021
Combined targeting of distinct c-Myc and JunB transcriptional programs for multiple myeloma therapy – Update: OeGHO Frühjahrstagung, 8.-10.4.2021, Online
Lind, J., Czernilofsky, F., Vallet, S., Fan, F., Bakiri, L., Wagner, E. F., Sattler, M., Pecherstorfer, M. & Podar, K., 2021, in: Memo - Magazine of European Medical Oncology. 14, Suppl. 2, S. 23-41 19 S.Publikation: Beitrag in Fachzeitschrift (peer-reviewed) › Konferenzbeitrag in Fachzeitschrift
Open Access -
OAB-030: Combined targeting of distinct c-Myc and JunB transcriptional programs induces synergistic anti-myeloma activity: 18th International Myeloma Workshop, 08.-11.09.2021, Vienna, Austria
Lind, J., Vallet, S., Kollmann, K., Aksoy, O., Sunder-Plassmann, V., Zwickl-Traxler, E., Fan, F., Stoiber-Sakaguchi, D., Bakiri, L., Wagner, E., Sattler, M., Pecherstorfer, M. & Podar, K., 2021, in: Clinical Lymphoma, Myeloma and Leukemia. 21, S. S19-S20Publikation: Beitrag in Fachzeitschrift (peer-reviewed) › Konferenzbeitrag in Fachzeitschrift
-
P-082: Delineating CDK9- regulated molecular events for the development of rationally derived multiple myeloma treatment strategies: 18th International Myeloma Workshop, 08.-11.09.2021, Vienna, Austria
Aksoy, O., Lind, J., Sunder-Plassmann, V., Pecherstorfer, M., Vallet, S. & Podar, K., 2021, in: Clinical Lymphoma, Myeloma and Leukemia. 21, S. S83-S84Publikation: Beitrag in Fachzeitschrift (peer-reviewed) › Konferenzbeitrag in Fachzeitschrift
-
2020
Combined targeting of distinct c-Myc and JunB transcriptional programs for multiple myeloma therapy: Abstractband für die Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020: Abstracts
Lind, J., Czernilofsky, F., Vallet, S., Fan, F., Bakiri, L., Wagner, E. F., Sattler, M., Pecherstorfer, M. & Podar, K., 2020, in: Oncology Research and Treatment. 43, Suppl. 4, S. 92Publikation: Beitrag in Fachzeitschrift (peer-reviewed) › Konferenzbeitrag in Fachzeitschrift
Open Access -
Quality of Life in Newly Diagnosed Patients with Multiple Myeloma Randomized to Either Krd or Ktd Induction Therapy Followed By Carfilzomib Maintenance or Control (AGMT MM 02 trial)
Ludwig, H., Melchardt, T., Andel, J., Gunsilius, E., Sormann, S., Hinke, A., Hartmann, B. L., Podar, K., Willenbacher, W., Egle, A., Petzer, A., Zojer, N., Wöll, E., Ruckser, R., Bozic, B., Schmitt, C. A., Machherndl-Spandl, S., Krauth, M-T., Schreder, M., Agis, H., &3 mehr, 2020, in: Blood. 136, Supplement 1, S. 27-29 3 S.Publikation: Beitrag in Fachzeitschrift (peer-reviewed) › Konferenzbeitrag in Fachzeitschrift
-
2019
Carfilzomib-Revlimid-Dexamethasone Vs. Carfilzomib-Thalidomide-Dexamethasone Weekly (After 2 Twice Weekly Cycles) Followed By Carfilzomib Maintenance Vs. Control in Transplant Non-Eligible Patients with Newly Diagnosed Multiple Myeloma (NDMM) - Interim Efficacy Analysis of Combined Data (AGMT MM-02): American Society of Hematology, 61th Annual Meeting, scientific session
Ludwig, H., Sormann, S., Zojer, N., Andel, J., Hartmann, B. L., Tinchon, C., Gunsilius, E., Podar, K., Egle, A., Willenbacher, W., Wöll, E., Ruckser, R., Bozic, B., Krauth, M-T., Petzer, A., Schmitt, C. A., Machherndl-Spandl, S., Agis, H., Paiva, B. & Greil, R., 2019, in: Blood. 134, Supplement_1, S. 696 1 S.Publikation: Beitrag in Fachzeitschrift (peer-reviewed) › Konferenzbeitrag in Fachzeitschrift
-
Combined Targeting of Distinct c-Myc and JunB Transcriptional Programs for Multiple Myelioma Therapy: American Society of Hematology, 61th Annual Meeting, scientific session
Lind, J., Czernilofsky, F., Vallet, S., Fan, F., Sattler, M., Bakiri, L., Wagner, E. F., Percherstorfer, M. & Podar, K., 2019, in: Blood. 134, Supplement_1, S. 4415 1 S.Publikation: Beitrag in Fachzeitschrift (peer-reviewed) › Konferenzbeitrag in Fachzeitschrift
-
Expanding on Current Definitions of Hematologic Improvement in MDS, CMML and AML: Landmark Analyses of 1301 Patients Treated with Azacitidine in the Austrian Registry of Hypomethylating Agents By the AGMT-Study Group: American Society of Hematology, 61th Annual Meeting, scientific session
Pleyer, L., Pfeilstocker, M., Stauder, R., Heibl, S., Sill, H., Girschikofsky, M., Stampfl-Mattersberger, M., Tinchon, C., Petzer, A., Schmitt, C. A., Vallet, S., Mandac, I., Geissler, K., Sperr, W. R., Leisch, M., Egle, A., Melchardt, T., Fusinato, J., Piringer, G., Zebisch, A., &4 mehr, 2019, in: Blood. 134, Supplement_1, S. 3821 1 S.Publikation: Beitrag in Fachzeitschrift (peer-reviewed) › Konferenzbeitrag in Fachzeitschrift
-
Multiple Myeloma Pathogenesis: The Role of Junb in Bone Marrow Angiogenesis: American Society of Hematology, 61th Annual Meeting, scientific session
Fan, F., Malvestiti, S., Shen, Y., Morelli, E., Mishima, Y., Seckinger, A., Hose, D., Bakiri, L., Vallet, S., Sattler, M., Roccaro, A. M., Goldschmidt, H., Percherstorfer, M., Sun, C., Hu, Y., Wagner, E. F., Tassone, P., Ghobrial, I. M., Jaeger, D. & Podar, K., 2019, in: Blood. 134, Supplement_1, S. 4341 1 S.Publikation: Beitrag in Fachzeitschrift (peer-reviewed) › Konferenzbeitrag in Fachzeitschrift